The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial Infarction
Abstract
Background —The benefit of catheter-based reperfusion for acute myocardial infarction (MI) is limited by a 5% to 15% incidence of in-hospital major ischemic events, usually caused by infarct artery reocclusion, and a 20% to 40% need for repeat percutaneous or surgical revascularization. Platelets play a key role in the process of early infarct artery reocclusion, but inhibition of aggregation via the glycoprotein IIb/IIIa receptor has not been prospectively evaluated in the setting of acute MI. Methods and Results —Patients with acute MI of <12 hours’ duration were randomized, on a double-blind basis, to placebo or abciximab if they were deemed candidates for primary PTCA. The primary efficacy end point was death, reinfarction, or any (urgent or elective) target vessel revascularization (TVR) at 6 months by intention-to-treat (ITT) analysis. Other key prespecified end points were early (7 and 30 days) death, reinfarction, or urgent TVR. The baseline clinical and angiographic variables of the 483 (242 placebo and 241 abciximab) patients were balanced. There was no difference in the incidence of the primary 6-month end point (ITT analysis) in the 2 groups (28.1% and 28.2%, P =0.97, of the placebo and abciximab patients, respectively). However, abciximab significantly reduced the incidence of death, reinfarction, or urgent TVR at all time points assessed (9.9% versus 3.3%, P =0.003, at 7 days; 11.2% versus 5.8%, P =0.03, at 30 days; and 17.8% versus 11.6%, P =0.05, at 6 months). Analysis by actual treatment with PTCA and study drug demonstrated a considerable effect of abciximab with respect to death or reinfarction: 4.7% versus 1.4%, P =0.047, at 7 days; 5.8% versus 3.2%, P =0.20, at 30 days; and 12.0% versus 6.9%, P =0.07, at 6 months. The need for unplanned, “bail-out” stenting was reduced by 42% in the abciximab group (20.4% versus 11.9%, P =0.008). Major bleeding occurred significantly more frequently in the abciximab group (16.6% versus 9.5%, P =0.02), mostly at the arterial access site. There was no intracranial hemorrhage in either group. Conclusions —Aggressive platelet inhibition with abciximab during primary PTCA for acute MI yielded a substantial reduction in the acute (30-day) phase for death, reinfarction, and urgent target vessel revascularization. However, the bleeding rates were excessive, and the 6-month primary end point, which included elective revascularization, was not favorably affected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301402 · Cited by 2,589
A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction
Grines, C. L., Browne, K. F., Marco, J., Rothbaum, D., Stone, G. W., O'Keefe, J., Overlie, P., Donohue, B., Chelliah, N., Timmis, G. C., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281001 · Cited by 1,995
(1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362401 · Cited by 1,883
Bayesian Statistics: An Introduction
Ziegel, E. R., & Lee, P. M. (1998) · Technometrics · doi:10.2307/1270551 · Cited by 1,115
Weaver, W. D. (1997) · JAMA · doi:10.1001/jama.1997.03550230069040 · Cited by 1,005
Investigators, T. R. (1997) · Circulation · doi:10.1161/01.cir.96.5.1445 · Cited by 945
Gibbons, R. J., Holmes, D. R., Reeder, G. S., Bailey, K. R., Hopfenspirger, M. R., & Gersh, B. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281003 · Cited by 815
Platelet Function in Acute Myocardial Infarction Treated With Direct Angioplasty
Gawaz, M., Neumann, F.-J., Ott, I., Schiessler, A., & Schömig, A. (1996) · Circulation · doi:10.1161/01.cir.93.2.229 · Cited by 302
Cited by
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.019 · Cited by 2,625
O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742c84 · Cited by 2,250
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.018 · Cited by 1,772
Guidelines for Percutaneous Coronary Interventions
Silber, S., Albertsson, P., Avilés, F. F., Camici, P. G., Colombo, A., Hamm, C., Jørgensen, E., Marco, J., Nordrehaug, J.-E., Ruzyllo, W., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi138 · Cited by 1,609
Management of acute myocardial infarction in patients presenting with ST-segment elevation
VandeWerf, F. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00618-8 · Cited by 1,448
Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction
Stone, G. W., Grines, C. L., Cox, D. A., Garcia, E., Tcheng, J. E., Griffin, J. J., Guagliumi, G., Stuckey, T., Turco, M., Carroll, J. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013404 · Cited by 1,277
Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction
Montalescot, G., Barragan, P., Wittenberg, O., Ecollan, P., Elhadad, S., Villain, P., Boulenc, J.-M., Morice, M.-C., Maillard, L., Pansiéri, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442503 · Cited by 1,186
Topol, E. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)85010-1 · Cited by 1,095
Self-citationMontalescot, G., Wiviott, S. D., Braunwald, E., Murphy, S. A., Gibson, C. M., McCabe, C. H., & Antman, E. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60441-4 · Cited by 1,068
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Priori, S. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2824 · Cited by 903
Recognition of the Importance of Embolization in Atherosclerotic Vascular Disease
Topol, E. J., & Yadav, J. S. (2000) · Circulation · doi:10.1161/01.cir.101.5.570 · Cited by 770
Self-citation(2013) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.24776 · Cited by 714
Antman, E. M., Giugliano, R. P., Gibson, C. M., McCabe, C. H., Coussement, P., Kleiman, N. S., Vahanian, A., Adgey, A. A. J., Menown, I., Rupprecht, H.-J., et al. (1999) · Circulation · doi:10.1161/01.cir.99.21.2720 · Cited by 681
Rezkalla, S. H., & Kloner, R. A. (2002) · Circulation · doi:10.1161/hc0502.102867 · Cited by 621
De Luca, G., Suryapranata, H., Stone, G. W., Antoniucci, D., Tcheng, J. E., Neumann, F.-J., Van de Werf, F., Antman, E. M., & Topol, E. J. (2005) · JAMA · doi:10.1001/jama.293.14.1759 · Cited by 614
Self-citationSmith, S. C., Dove, J. T., Jacobs, A. K., Kennedy, J. W., Kereiakes, D., Kern, M. J., Kuntz, R. E., Popma, J. J., Schaff, H. V., Williams, D. O., et al. (2001) · Circulation · doi:10.1161/01.cir.103.24.3019 · Cited by 608
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction
Ryan, T. J., Antman, E. M., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., Riegel, B., Russell, R. O., Smith, E. E., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00351-4 · Cited by 592
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.001 · Cited by 532
Topol, E. J., Byzova, T. V., & Plow, E. F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11086-3 · Cited by 528
Self-citationSchömig, A., Kastrati, A., Dirschinger, J., Mehilli, J., Schricke, U., Pache, J., Martinoff, S., Neumann, F.-J., & Schwaiger, M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008103430602 · Cited by 475
Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., & Stevenson, W. (2006) · Circulation · doi:10.1161/circulationaha.106.655688 · Cited by 437
Dalby, M., Bouzamondo, A., Lechat, P., & Montalescot, G. (2003) · Circulation · doi:10.1161/01.cir.0000091088.63921.8c · Cited by 432
ACC/AHA/SCAI Practice Guidelines, February 21, 2006
(2006) · Circulation · doi:10.1161/circulationaha.106.173220 · Cited by 422
Patrono, C. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.013 · Cited by 408
(2003) · OECD Health Working Papers · doi:10.1787/230112362071 · Cited by 381
Topol, E. J., Mark, D. B., Lincoff, A. M., Cohen, E., Burton, J., Kleiman, N., Talley, D., Sapp, S., Booth, J., Cabot, C. F., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10018-7 · Cited by 324
Self-citationBashore, T. M., Bates, E. R., Berger, P. B., Clark, D. A., Cusma, J. T., Dehmer, G. J., Kern, M. J., Laskey, W. K., O’Laughlin, M. P., Oesterle, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01346-8 · Cited by 320
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article
Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.025 · Cited by 310
Boersma, E., Mercado, N., Poldermans, D., Gardien, M., Vos, J., & Simoons, M. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12712-2 · Cited by 305
Thiele, H., Schindler, K., Friedenberger, J., Eitel, I., Fürnau, G., Grebe, E., Erbs, S., Linke, A., Möbius-Winkler, S., Kivelitz, D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.747642 · Cited by 303
Yip, H.-K., Chen, M.-C., Chang, H.-W., Hang, C.-L., Hsieh, Y.-K., Fang, C.-Y., & Wu, C.-J. (2002) · Chest · doi:10.1378/chest.122.4.1322 · Cited by 292
Marso, S. P., Lincoff, A. M., Ellis, S. G., Bhatt, D. L., Tanguay, J.-F., Kleiman, N. S., Hammoud, T., Booth, J. E., Sapp, S. K., & Topol, E. J. (1999) · Circulation · doi:10.1161/01.cir.100.25.2477 · Cited by 288
Self-citationShifting the open-artery hypothesis downstream: the quest for optimal reperfusion
Roe, M. T., Ohman, E. M., Maas, A. C. P., Christenson, R. H., Mahaffey, K. W., Granger, C. B., Harrington, R. A., Califf, R. M., & Krucoff, M. W. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01101-3 · Cited by 258
De Luca, G., Navarese, E., & Marino, P. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp118 · Cited by 252
Palmer, S. C., Di Micco, L., Razavian, M., Craig, J. C., Perkovic, V., Pellegrini, F., Copetti, M., Graziano, G., Tognoni, G., Jardine, M., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-6-201203200-00007 · Cited by 204
Kim, J.-S., Kim, J., Choi, D., Lee, C. J., Lee, S. H., Ko, Y.-G., Hong, M.-K., Kim, B.-K., Oh, S. J., Jeon, D. W., et al. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.11.021 · Cited by 183
Metadata
- Authors
- Brener, S. J., Barr, L. A., Burchenal, J. E. B., Katz, S., George, B. S., Jones, A. A., Cohen, E. D., Gainey, P. C., White, H. J., Cheek, H. B., Moses, J. W., Moliterno, D. J., Effron, M. B., & Topol, E. J.
- Venue
- Circulation
- Published
- 1998-08-25
- Volume
- 98
- Issue
- 8
- Pages
- 734-741
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2124788115
- Cited by
- 722
- References
- 13
- FWCI
- 57.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.